United Kingdom· GB-APID-32861211000001101
Tolazamide 500mg tablets
A tolazamide product containing tolazamide, registered in United Kingdom by Imported (United States). The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Tolazamide is registered in 2 of 19 countries.
Countries holding a registration under ATC A10BB05 (tolazamide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Tolazamide · ATC A10BB05
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tolazamide
- Manufacturer
- Imported (United States)
- Country
- United Kingdom (GB)
- ATC code
- A10BB05
- ATC class
- Tolazamide
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
509 interactions on record for tolazamide.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolazamide · interactions on record
509 records
- 20 severe
- 439 moderate
- 50 minor
Most severe, free to view
- MiconazoleA07AC01severe
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10BB05
Tolazamide, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c1202e7-77da-4926-bb48-df3f7b3887a0 GET /v1/drugs/7c1202e7-77da-4926-bb48-df3f7b3887a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "32861211000001101",
"desc": "Tolazamide 500mg tablets (Imported (United States))",
"form": "Oral tablet",
"vpid": "42090511000001105",
"source": "dmd",
"vtm_id": "777796007",
"strength": "500 mg",
"substance": "Tolazamide",
"ingredient": "Tolazamide",
"supplier_code": "11821411000001108"
}See everything about tolazamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.